International Stem Cell Stock Fundamentals
| ISCO Stock | USD 0.10 0.01 9.09% |
International Stem Cell fundamentals help investors to digest information that contributes to International Stem's financial success or failures. It also enables traders to predict the movement of International OTC Stock. The fundamental analysis module provides a way to measure International Stem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to International Stem otc stock.
International |
International Stem Cell OTC Stock Profit Margin Analysis
International Stem's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current International Stem Profit Margin | (0.09) % |
Most of International Stem's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, International Stem Cell is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, International Stem Cell has a Profit Margin of -0.0929%. This is 99.17% lower than that of the Biotechnology sector and 99.6% lower than that of the Health Care industry. The profit margin for all United States stocks is 92.69% lower than that of the firm.
International Stem Cell Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining International Stem's current stock value. Our valuation model uses many indicators to compare International Stem value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across International Stem competition to find correlations between indicators driving International Stem's intrinsic value. More Info.International Stem Cell is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value International Stem by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for International Stem's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.International Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses International Stem's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of International Stem could also be used in its relative valuation, which is a method of valuing International Stem by comparing valuation metrics of similar companies.International Stem is currently under evaluation in profit margin category among its peers.
International Fundamentals
| Return On Equity | -6.92 | |||
| Return On Asset | -0.0685 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.07) % | |||
| Current Valuation | 5.11 M | |||
| Shares Outstanding | 8 M | |||
| Shares Owned By Insiders | 53.77 % | |||
| Price To Earning | 103.12 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 7.18 M | |||
| Gross Profit | 4.24 M | |||
| EBITDA | (509 K) | |||
| Net Income | (899 K) | |||
| Cash And Equivalents | 586 K | |||
| Cash Per Share | 0.07 X | |||
| Total Debt | 4.31 M | |||
| Current Ratio | 0.64 X | |||
| Book Value Per Share | (0.58) X | |||
| Cash Flow From Operations | (1.3 M) | |||
| Earnings Per Share | (0.04) X | |||
| Target Price | 0.54 | |||
| Number Of Employees | 26 | |||
| Beta | 0.65 | |||
| Market Capitalization | 1.68 M | |||
| Total Asset | 4.95 M | |||
| Retained Earnings | (114.79 M) | |||
| Working Capital | (2.55 M) | |||
| Current Asset | 2.99 M | |||
| Current Liabilities | 5.54 M | |||
| Z Score | -31.2 | |||
| Net Asset | 4.95 M |
About International Stem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze International Stem Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of International Stem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of International Stem Cell based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California. International Stem operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 26 people.
Pair Trading with International Stem
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if International Stem position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in International Stem will appreciate offsetting losses from the drop in the long position's value.Moving against International OTC Stock
| 0.48 | PBCRY | Bank Central Asia | PairCorr |
| 0.46 | BKRKY | Bank Rakyat Normal Trading | PairCorr |
| 0.45 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.44 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.43 | PBCRF | PT Bank Central | PairCorr |
The ability to find closely correlated positions to International Stem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace International Stem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back International Stem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling International Stem Cell to buy it.
The correlation of International Stem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as International Stem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if International Stem Cell moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for International Stem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in International OTC Stock
International Stem financial ratios help investors to determine whether International OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Stem security.